Validation of recombinant PPD in Tuberculosis diagnosis infection

niversidade Federal do Rio de Janeiro0 个研究点开始时间: 2021年1月25日最近更新: 2023年11月13日

适应症

试验速览

暂无简介。

•Active tuberculosis group; adults between eighteen (18) and fifty-nine (59) years of age; Bacteriologically confirmed tuberculosis undergoing treatment; women with a negative urine pregnancy test and/or who are not breastfeeding; provision of the Free and Informed Consent Form;
•Group control; adults between eighteen (18) and fifty-nine (59) years of age; asymptomatic; women with a negative urine pregnancy test and/or who are not breastfeeding; provision of the Free and Informed Consent Form

•Active tuberculosis group: patients with diabetes mellitus; malignant neoplasm; immunosuppression with the use of immunobiological; Lupus Erythematosus; Crohn's disease; patients with fibromyalgia syndrome; in use of homeopathic medicine; subjects previously infected with non-tuberculous mycobacteria not indicated or not known; Individuals with documented positive skin test of tuberculin examination in the past (documented or referred by the participant), with report of exacerbated reaction defined as phlyctenule reaction;
•Control Group: patients with diabetes mellitus; malignant neoplasm; immunosuppression with the use of immunobiological; Lupus Erythematosus; Crohn's disease; patients with fibromyalgia syndrome; in use of homeopathic medicine; individuals previously infected with nontuberculous mycobacteria; individuals reporting contact with pulmonary tuberculosis in the past; individuals who reported treatment for active tuberculosis in the past; individuals with a positive tuberculin skin test in the past (documented or referred by the participant), with a report of an exacerbated reaction defined as a phlyctenule reaction;

发起方

niversidade Federal do Rio de Janeiro